Table 5

ORsa and 95% CIs for prostate cancer in relation to waist and hip circumferences and WHR, Shanghai, China

QuartilesbPtrend
1234
Waist circumference (cm)c<75  75–82.382.4–89.389.4–115.0
Total prostate cancer1.001.27(0.80–2.00)d1.20(0.77–1.89)0.89(0.55–1.44)0.63
Localized prostate cancer1.001.90(0.88–4.07)1.97(0.92–4.18)1.78(0.81–3.92)0.19
Regional/remote prostate cancer1.001.05(0.62–1.75)0.93(0.56–1.55)0.58(0.33–1.03)0.07
Hip circumference (cm)c<86.086.1–91.992.0–97.397.4–122.8
Total prostate cancer1.000.53(0.34–0.83)0.53(0.34–0.83)0.46(0.29–0.74)0.001
Localized prostate cancer1.000.42(0.20–0.88)0.80(0.42–1.53)0.61(0.30–1.23)0.41
Regional/remote prostate cancer1.000.55(0.33–0.91)0.40(0.23–0.69)0.38(0.22–0.67)0.0002
WHRe<0.860.87–0.890.90–0.920.93–1.12
Total prostate cancer1.001.23(0.72–2.10)2.15(1.31–3.52)2.71(1.66–4.41)0.0001
Localized prostate cancer1.001.23(0.49–3.13)2.68(1.17–6.16)4.20(1.88–9.36)0.0001
Regional/remote prostate cancer1.001.28(0.70–2.36)1.98(1.12–3.52)2.09(1.18–3.70)0.0036
  • a Adjusted for age, education, marital status, total calories, and BMI.

  • b Based on the distribution among 471 controls.

  • c Measured at interview.

  • d 95% CIs.

  • e Based on waist and hip circumference measured at interview.